Last 19,100 KRW
Change Today +900.00 / 4.95%
Volume 136.3K
002620 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:27 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

jeil pharmaceutical co (002620) Snapshot

Open
18,200
Previous Close
18,200
Day High
19,500
Day Low
18,200
52 Week High
08/13/14 - 33,600
52 Week Low
11/8/13 - 12,300
Market Cap
283.6B
Average Volume 10 Days
285.7K
EPS TTM
133.00
Shares Outstanding
14.9M
EX-Date
12/27/13
P/E TM
143.6x
Dividend
40.00
Dividend Yield
0.21%
Current Stock Chart for JEIL PHARMACEUTICAL CO (002620)

Related News

No related news articles were found.

jeil pharmaceutical co (002620) Related Businessweek News

No Related Businessweek News Found

jeil pharmaceutical co (002620) Details

Jeil Pharmaceutical Co., Ltd. develops and supplies pharmaceutical products primarily in South Korea. The company produces solid medicines and injections; finished pharmaceutical products, including patches; and active pharmaceutical ingredients, such as anti-biotic ingredients, etc. It offers products in therapeutic areas, such as antibiotic, oncology, cardiovascular, gestrointestinal, neuropsychiatry, alimentary, urology, endocrinology, respiratory, thyroid and related drugs, antiviral, dermatology, dermal patches, and NSAIDs. Jeil Pharmaceutical Co., Ltd. also exports its products to approximately 50 countries in ASEAN, Central and South America, Africa, etc. The company was formerly known as Jeil Pharmaceutical Industry Corporation and changed its name to Jeil Pharmaceutical Co., Ltd. in July 1976. Jeil Pharmaceutical Co., Ltd. was founded in 1959 and is headquartered in Seoul, South Korea.

Founded in 1959

jeil pharmaceutical co (002620) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jeil pharmaceutical co (002620) Key Developments

Jeil Pharmaceutical Co., Ltd., Annual General Meeting, Mar 21, 2014

Jeil Pharmaceutical Co., Ltd., Annual General Meeting, Mar 21, 2014., at 10:00 Korea Standard Time. Location: Seoul 343 as Siping (The building 12th floor conference room medicine). Agenda: To consider audit reports and sales reports; to consider approval of financial statements; to consider appointment of corporate director; and to consider approval of director remuneration.

Jeil Pharmaceutical Co., Ltd., Annual General Meeting, Mar 15, 2013

Jeil Pharmaceutical Co., Ltd., Annual General Meeting, Mar 15, 2013., at 10:00 Korea Standard Time. Location: Banpo-dong, Seocho-gu, 745-5 Best drugs Building 12 Floor Conference Room. Agenda: To report audit reports and sales reports; to approve financial statements; to consider incorporation of some changes; and to consider appointment of outside directors on the audit committee.

Jeil Pharmaceutical Co., Ltd. Presents at BIO-Europe 2012, Nov-12-2012

Jeil Pharmaceutical Co., Ltd. Presents at BIO-Europe 2012, Nov-12-2012 . Venue: CCH Congress Center Hamburg, Am Dammtor / Marseiller Str, 20355 Hamburg, Germany.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002620:KS 19,100.00 KRW +900.00

002620 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002620.
View Industry Companies
 

Industry Analysis

002620

Industry Average

Valuation 002620 Industry Range
Price/Earnings 100.0x
Price/Sales 0.5x
Price/Book 0.9x
Price/Cash Flow 123.8x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JEIL PHARMACEUTICAL CO, please visit www.jeilpharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.